Cargando…

OR14-002 - ANTI IL-1 therapies and pregnancy outcome

Detalles Bibliográficos
Autores principales:	Lachmann, HJ, Ozdogan, H, Simon, A, Stewart, N, Rowczenio, DM, Ugurlu, S, Lane, T, Hawkins, PN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952230/ http://dx.doi.org/10.1186/1546-0096-11-S1-A269

Ejemplares similares

P03-017 - Health related quality of life in adult with HRFS
por: Lachmann, HJ, et al.
Publicado: (2013)

PW03-020 – A decade of ANTI-IL-1 therpay for CAPS in the UK
por: Lane, T, et al.
Publicado: (2013)

OR14-001 – Tocilizumab in autoinflammation and AA amyloidosis
por: Lane, T, et al.
Publicado: (2013)

P02-010 - A novel 24 nucleotide deletion in the TNFRSF1A
por: Rowczenio, DM, et al.
Publicado: (2013)

PW01-021 – The phenotype of FMF due to deletion M694
por: Lachmann, HJ, et al.
Publicado: (2013)

PW02-014 - Long term outcome and quality of life in TRAPS
por: Lane, T, et al.
Publicado: (2013)

PW02-030 - Clinical phenotype in individuals with Q703K
por: Rowczenio, DM, et al.
Publicado: (2013)

PW02-015 - Eight years HPFS experience in a single UK centre
por: Rowczenio, DM, et al.
Publicado: (2013)

A decade of anti-IL-1 therapy in CAPS - a spectrum of efficacy in this spectrum of diseases
por: Lane, T, et al.
Publicado: (2015)

Empirical use of anakinra in AA amyloidosis of uncertain aetiology
por: Lane, T, et al.
Publicado: (2015)

OR7-002 – Pyrin 577 mutations in dominant autoinflammation
por: Stoffels, M, et al.
Publicado: (2013)

P02-002 - IL36RN mutations in patients with DITRA
por: Arostegui, JI, et al.
Publicado: (2013)

OR3-002 – Blau Syndrome cohort study: ocular outcome
por: Rose, CD, et al.
Publicado: (2013)

OR5-002 – In vitro studies in Schnitzler’s syndrome
por: De Koning, HD, et al.
Publicado: (2013)

P01-011 – Colchicine compliance and amyloidosis
por: Ozdogan, H, et al.
Publicado: (2013)

OR6-002 – Thromboembolism in autoinflammatory syndromes
por: Vaitla, PM, et al.
Publicado: (2013)

OR2-002 – The risk of FMF in MEFV heterozygotes
por: Jéru, I, et al.
Publicado: (2013)

OR11-002 - Mutations in MVK cause non-syndromic RP
por: Siemiatkowska, AM, et al.
Publicado: (2013)

PW03-030 – Collecting patients data to inform genetic studies
por: Bybee, AK, et al.
Publicado: (2013)

P03-002 - Different phenotypes associated with Q703K variant
por: von Scheven-Gête, A, et al.
Publicado: (2013)

PW01-012 – Canakinumab in patients with FMF
por: Ugurlu, S, et al.
Publicado: (2013)

P01-002 – Comparison between different colchicines responders
por: Özçakar, ZB, et al.
Publicado: (2013)

PW03-002 – Calculating Gaslini diagnostic score in PFAPA
por: Bosio, I, et al.
Publicado: (2013)

PW01-002 – Colchicine resistant FMF in Turkish children
por: Eroglu, FK Kara, et al.
Publicado: (2013)

PW02-002 - Single MVK mutation and recurrent fevers
por: Barron, K, et al.
Publicado: (2013)

P02-015 - A novel MVK mutation in a child with AA amyloid
por: Kolsky, A, et al.
Publicado: (2013)

P01-015 – Effect of Cochicine on cholesterol in FMF and BS
por: Ugurlu, S, et al.
Publicado: (2013)

OR10-002 - A novel TNFR1 transcript of TRAPS gene
por: Rittore, C, et al.
Publicado: (2013)

PW01-015 – Canakinumab in adults with colchicin resistant FMF
por: Gül, A, et al.
Publicado: (2013)

International experience of pregnancy outcomes in auto-inflammatory syndromes treated with Interleukin-1 inhibitors
por: Youngstein, T, et al.
Publicado: (2015)

PW02-011 - Favorable response to anakinra in aisle patients
por: Ozdogan, H, et al.
Publicado: (2013)

Downregulation of macrophage IL-12 production by tumor-derived IL-11
por: Torroella, M, et al.
Publicado: (2001)

Inhibition of neutrophil respiratory burst and degranulation responses by CVT-E002, the main active ingredient in COLD-FX
por: Pillai, Renjith, et al.
Publicado: (2011)

Diagnostic value of fat aspirates for amyloidosis in 950 patients
por: Gilbertson, JA, et al.
Publicado: (2015)

PW02-031 - Genetic and clinical manifestations of CAPS
por: Bybee, AK, et al.
Publicado: (2013)

P03-016 - ANTI IL1 refractory CINCA respondes to ANTI IL6
por: Dueckers, G, et al.
Publicado: (2013)

OR13-002 Recessive mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause systemic and cutaneous polyarteritis nodosa (PAN)
por: Levy-Lahad, E, et al.
Publicado: (2013)

sCD14, IL-6 and TNF-receptors, but not IL-1, IL-8 or TNF-α are elevated in plasma of patients undergoing high risk coronary angioplasty with cardiopulmonary support
por: Prondzinsky, R, et al.
Publicado: (1999)

The human chaperone BiP stimulates interleukin(IL)-10 producing CD8 T cells: implications for rheumatoid arthritis
por: Bodman-Smith, MD, et al.
Publicado: (2002)

OR10-006 - Canakinumab in patients with TRAPS
por: Lachmann, HJ, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ltgvbl97r6g2m48icls2g6ph0m